Abstract:According to the classification of ISSVA, Waner and Suen, the traditionally called lymphangiomas are now referred to as lymphatic malformations, including both macrocystic and microcystic lesions. They are commonly seen vascular anomalies, and most frequently diagnosed at birth and most often occur in the head and neck area. The etiology of lymphatic malformations is still unknown, resulting in a variety of treatment modalities. This paper reviewed the recent literatures with respect to the indications, contraindications, advantages and disadvantages of surgical excision, sclerotherapy and laser ablation of lymphatic malformations of the head and neck, with detailed discussion of the advances in molecular biology and clinical treatment prospects. It is concluded that although lymphatic malformations are benign lesions, they seldom involute spontaneously. Of all vascular malformations, lymphatic malformations are the most difficult to be eradicated. Their infiltrating nature coupled with the difficulty in distinguishing involved important structures of the head and neck from adjacent normal tissues makes complete surgical extirpation even more difficult. The likelihood of postsurgical recurrence and complications is thus higher than other vascular lesions. Although many treatment protocols are available in clinic, indications, contraindications, advantages and disadvantages exist in each modality. The selection of treatment modalities should depend on the patients' status and techniques available. The treatment protocol should be individualized and comprehensive as well as sequential, in order to obtain the best treatment outcomes. In general, treatment will vary according to the depth and the extent of the lesions. Superficial mucosal microcystic lesions and cervicofacial macrocystic lesions are amenable to ablation with sclerotherapy using Bleomycin and OK-432 with the advantages of the absence of a surgical scar. The sclerosing agent OK-432 is effective for macrocystic lymphatic malformations but showed less promise for microcystic lesions, mixed lesions, and lesions outside the head and neck region. In addition, superficial mucosal microcystic lesions are also amenable to CO2 laser therapy. Deeper microcystic lesions are still challenging head and neck surgeons, which are usually extensive and sometimes need to be resected in stages, and even may be impossible to be completely removed. Somnoplasty shows promise for reduction of tongue lymphatic malformations. Surgical excision, staged when necessary, continues to be integral to management in many cases, but should not be overused without consideration of the histologic types and extent. Localized mucosal microcystic lesions and major cervicofacial macrocystic lesions are amenable to primary excision. Care should be exercised in identifying and preserving important cervical and facial structures because anatomical planes are often distorted. Combined sequential approach is recommended for mixed lesions as well as extensive lesions involving both the mucosa and soft tissues.

Dual-agent percutaneous sclerotherapy technique for macrocystic lymphatic malformations

Successful Sclerotherapy for Cervicofacial Macrocystic Lymphatic Malformations Using Polidocanol and Pingyangmycin Combined Foam Sclerosants

Management of Macrocystic Lymphatic Malformation in the Cervicofacial Region: Ultrasound-Guided Iodine Tincture Cauterization Combined With Intralesional Negative Pressure

Bleomycin Sclerotherapy for Large Diffuse Microcystic Lymphatic Malformations.

Management of Lymphatic Malformations in Oral and Maxillofacial Regions: the Rationale According to the New Classification

Highly Selective Electrocoagulation Therapy: an Innovative Treatment for Lymphangioma Circumscriptum

Simulated Angiography Using a Bleomycin Mixture for Sclerotherapy of Lymphatic Malformations

Doxycycline Sclerotherapy of Aneurysmal and Unicameral Bone Cysts in the Appendicular Skeleton and Pelvis: Single-Center 14-Year Experience

Efficacy of Bleomycin-Lauromacrogol Foam in Pediatric Macrocystic Lymphatic Malformations With and Without Intracapsular Hemorrhage

Sclerotherapy of venous malformation in children：selection of method and its technique

Abstract No. 584 Percutaneous Sclerotherapy of Lymphatic Malformations: Outcomes at a Tertiary Care Pediatric Center

Pingyangmycin albumin foam sclerotherapy of microcystic lymphatic malformation of the tongue

Doxycycline Sclerotherapy of Mandibular Aneurysmal Bone Cysts: A Brief Clinical Study

[Application of surgery combined with bleomycin irrigation for complex cervical-facial lymphatic malformations in children]

Atypical Calf Cyst Treated With Doxycycline Sclerotherapy: A Case Report

Surgery versus sclerotherapy versus combined therapy in head and neck lymphatic malformations in the pediatric population: systematic review and meta-analysis

Sclerotherapy of the Post renal Transplant Lymphoceles: A Meta-Analysis

Embolic Agents: Sclerotherapy

Surgical Deroofing and Trichloroacetic Acid Application: A Novel Treatment for Digital Mucous Cysts

Intra-lesional Injection for the Treatment of Oral and Maxillofacial Lymphatic-Capillary Malformation in Infants and Children

Treatment of Residual Venous Malformations after Surgical Resection Using Interventional Sclerotherapy